Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Operations: 2019-2024

Historic Cash from Operations for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$24.7 million.

  • MDxHealth's Cash from Operations rose 56.63% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.1 million, marking a year-over-year increase of 59.82%. This contributed to the annual value of -$24.7 million for FY2024, which is 9.53% up from last year.
  • As of FY2024, MDxHealth's Cash from Operations stood at -$24.7 million, which was up 9.53% from -$27.3 million recorded in FY2023.
  • Over the past 5 years, MDxHealth's Cash from Operations peaked at -$24.7 million during FY2024, and registered a low of -$37.9 million during FY2022.
  • Over the past 3 years, MDxHealth's median Cash from Operations value was -$27.3 million (recorded in 2023), while the average stood at -$30.0 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first surged by 37.17% in 2020, then tumbled by 41.20% in 2022.
  • Over the past 5 years, MDxHealth's Cash from Operations (MRY) stood at -$27.1 million in 2020, then increased by 1.04% to -$26.8 million in 2021, then crashed by 41.20% to -$37.9 million in 2022, then grew by 27.90% to -$27.3 million in 2023, then grew by 9.53% to -$24.7 million in 2024.
  • Its last three reported values are -$24.7 million in FY2024, -$27.3 million for FY2023, and -$37.9 million during FY2022.